Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RAJESH BEHL

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1104844174
CMS profile
276358
Location
BERKELEY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$164,983.60

342 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
Janssen Biotech, Inc. $35,382.59 49
ABBVIE INC. $33,806.09 36
Karyopharm Therapeutics Inc. $26,807.78 19
Genmab U.S., Inc. $14,707.20 20
Incyte Corporation $14,048.06 22
Novartis Pharmaceuticals Corporation $13,114.77 11
Kite Pharma, Inc. $11,054.75 18
E.R. Squibb & Sons, L.L.C. $5,496.51 19
Syndax Pharmaceuticals, Inc. $4,386.73 6
Invivyd Inc $2,838.43 2
Merck Sharp & Dohme LLC $391.48 14
Takeda Pharmaceuticals U.S.A., Inc. $293.76 22
AstraZeneca Pharmaceuticals LP $279.92 11
ARRAY BIOPHARMA INC $265.66 11
Celgene Corporation $219.62 12
PFIZER INC. $182.47 8
JAZZ PHARMACEUTICALS INC. $133.39 4
GlaxoSmithKline, LLC. $120.31 4
Integra LifeSciences Corporation $112.81 2
Agios Pharmaceuticals, Inc. $100.75 3
GENZYME CORPORATION $86.04 3
Boehringer Ingelheim Pharmaceuticals, Inc. $84.93 3
Iovance Biotherapeutics, Inc. $77.96 3
Eisai Inc. $76.62 3
Daiichi Sankyo Inc. $74.48 3
BeOne Medicines USA, Inc. $68.92 3
SpringWorks Therapeutics, Inc. $48.42 2
Gilead Sciences, Inc. $48.41 2
Exelixis Inc. $44.72 1
Astellas Pharma US Inc $41.49 2
SOBI, INC $36.37 1
Ipsen Biopharmaceuticals, Inc $34.57 1
Tempus AI, Inc $33.67 2
Coherus Oncology, Inc. $32.84 1
Spectrum Pharmaceuticals Inc. $30.58 1
PharmaEssentia USA Corporation $29.04 1
Genentech USA, Inc. $28.87 1
Aveo Pharmaceuticals, Inc. $28.51 1
Alexion Pharmaceuticals, Inc. $27.94 1
PUMA BIOTECHNOLOGY, INC. $26.86 1
KYOWA KIRIN, INC. $26.77 1
Fennec Pharmaceuticals, Inc. $25.09 1
Janssen Pharmaceuticals, Inc $24.23 2
Legend Biotech USA Inc. $24.20 1
BeiGene USA, Inc. $23.90 1
Lilly USA, LLC $23.73 1
Rigel Pharmaceuticals, Inc. $22.95 1
RECORDATI_RARE_DISEASES_INC. $22.82 1
Deciphera Pharmaceuticals Inc. $21.95 1
EMD Serono, Inc. $21.85 1
ADC THERAPEUTICS AMERICA, INC. $21.50 1
SANOFI US SERVICES INC. $20.29 1

Page 6 of 7; records 251–300 of 342 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RAJESH BEHL

NPI 1104844174 · CMS profile ID 276358

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

BERKELEY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 6 of 7; records 251–300 of 342 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1104844174?year=2025&recipient=provider&page=6#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RAJESH BEHL, NPI 1104844174, CMS profile ID 276358. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 6 of 7; records 251–300 of 342 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1104844174?year=2025&recipient=provider&page=6#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). RAJESH BEHL, NPI 1104844174, CMS profile ID 276358. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 6 of 7; records 251–300 of 342 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1104844174?year=2025&recipient=provider&page=6#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
RAJESH BEHL, NPI 1104844174, CMS profile ID 276358, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 6 of 7; records 251–300 of 342 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1104844174?year=2025&recipient=provider&page=6#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

342 matching records · $164,983.60 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 342 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 251–300 of 342.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Kite Pharma, Inc. $526.9605/02/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212090853 CMS
Novartis Pharmaceuticals Corporation $38.5605/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200164310 CMS
ABBVIE INC. $122.3104/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201494089 CMS
ABBVIE INC. $977.7504/30/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1201494091 CMS
Karyopharm Therapeutics Inc. $775.0004/29/2025 Honoraria No dispute reported Delay: No
Change: NEW
06/30/2026 1246650720 CMS
Incyte Corporation $1,100.0004/28/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1226165010 CMS
Merck Sharp & Dohme LLC $30.9304/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238083893 CMS
Iovance Biotherapeutics, Inc. $26.1204/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251398029 CMS
GlaxoSmithKline, LLC. $25.2804/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190646164 CMS
Exelixis Inc. $44.7204/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218801725 CMS
ABBVIE INC. $3,000.0004/18/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1201494087 CMS
Agios Pharmaceuticals, Inc. $45.3104/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1253244858 CMS
Janssen Biotech, Inc. $14.5204/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174560431 CMS
E.R. Squibb & Sons, L.L.C. $40.9904/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184571815 CMS
Takeda Pharmaceuticals U.S.A., Inc. $0.6904/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223796132 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.4804/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223877909 CMS
ARRAY BIOPHARMA INC $23.4904/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230054189 CMS
ARRAY BIOPHARMA INC $4.3804/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230072125 CMS
Karyopharm Therapeutics Inc. $3,875.0004/15/2025 Honoraria No dispute reported Delay: No
Change: NEW
06/30/2026 1246650724 CMS
Karyopharm Therapeutics Inc. $121.8204/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246650728 CMS
Karyopharm Therapeutics Inc. $26.6004/15/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1246650732 CMS
E.R. Squibb & Sons, L.L.C. $0.6404/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184571809 CMS
E.R. Squibb & Sons, L.L.C. $21.8904/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184571811 CMS
E.R. Squibb & Sons, L.L.C. $0.6404/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184571813 CMS
Janssen Biotech, Inc. $25.2004/12/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1174558188 CMS
Janssen Biotech, Inc. $82.6604/12/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1174558697 CMS
Spectrum Pharmaceuticals Inc. $30.5804/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1221050848 CMS
Janssen Biotech, Inc. $2,860.0004/08/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1174558928 CMS
PFIZER INC. $28.1804/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230081579 CMS
Janssen Biotech, Inc. $145.4004/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174559366 CMS
PUMA BIOTECHNOLOGY, INC. $26.8604/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251747339 CMS
Novartis Pharmaceuticals Corporation $102.0003/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200096988 CMS
Novartis Pharmaceuticals Corporation $75.6403/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200096990 CMS
Novartis Pharmaceuticals Corporation $5,500.0003/29/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1200096992 CMS
Novartis Pharmaceuticals Corporation $162.6303/29/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1200096994 CMS
Novartis Pharmaceuticals Corporation $134.3303/29/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1200096996 CMS
Novartis Pharmaceuticals Corporation $734.1003/29/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1200096998 CMS
Takeda Pharmaceuticals U.S.A., Inc. $7.8103/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223803492 CMS
Takeda Pharmaceuticals U.S.A., Inc. $12.9403/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223809210 CMS
Karyopharm Therapeutics Inc. $122.2703/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246650747 CMS
Karyopharm Therapeutics Inc. $3,875.0003/27/2025 Honoraria No dispute reported Delay: No
Change: NEW
06/30/2026 1246650750 CMS
Karyopharm Therapeutics Inc. $20.3003/27/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1246650754 CMS
Syndax Pharmaceuticals, Inc. $26.0803/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238989886 CMS
BeOne Medicines USA, Inc. $20.5103/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202884582 CMS
ABBVIE INC. $218.8503/21/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1201494083 CMS
ABBVIE INC. $28.0403/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201494085 CMS
Janssen Biotech, Inc. $2,860.0003/21/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1174558735 CMS
Celgene Corporation $19.1603/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184571799 CMS
Janssen Biotech, Inc. $128.7503/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174559290 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $34.2303/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223043137 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $49,418.30 100
PY2020 $19,881.08 26
PY2021 $79,546.91 66
PY2022 $153,919.88 123
PY2023 $59,789.29 58
PY2024 $56,386.25 61
PY2025 $164,983.60 342

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $123,997.55 7
PY2024 Principal investigator $307,747.83 17
PY2023 Recipient $35.00 1
PY2023 Principal investigator $8,996.00 7
PY2022 Principal investigator $64,005.70 9
PY2021 Principal investigator $8,000.00 3
PY2020 Principal investigator $14,784.00 10
PY2019 Principal investigator $21,410.70 26

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

7 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Incyte Corporation $3,450.00 09/25/2025 Covered Recipient Teaching Hospital
Sutter Santa Rosa Regional Hospital
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Combination of PI3Kd Inhibitor Parsaclisib and Ruxolitinib in Participants With Myelofibrosis No dispute reported 06/30/2026 1240483365
Principal investigator 1 Celgene Corporation $1,875.00 05/28/2025 Covered Recipient Teaching Hospital
Cpmc-R.K. Davies Medical Center
Connect Myeloid: The Myelofibrosis (MF), Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry. The purpose of the Connect Myeloid disease registry is to provide unique insights into treatment decisions and treatment patterns as they relate to clinical outcomes of patients with myeloid diseases in routine clinical practice. No dispute reported 06/30/2026 1222305159
Principal investigator 1 ABBVIE INC. $15,053.18 04/03/2025 Covered Recipient Teaching Hospital
SUTTER SANTA ROSA REGIONAL HOSPITAL
A Phase 3 Multicenter Randomized Open-Label Trial to Evaluate Safety and Efficacy of Epcoritamab in Combination with R-CHOP compared to R-CHOP in Subjects with High-Risk Diffuse Large B-Cell Lymphoma No dispute reported 06/30/2026 1202422086
Principal investigator 1 ABBVIE INC. $6,907.23 03/07/2025 Covered Recipient Teaching Hospital
SUTTER SANTA ROSA REGIONAL HOSPITAL
M20-621 - A Phase 3 Multicenter Randomized Open-Label Trial to Evaluate Safety and Efficacy of Epcoritamab in Combination with R-CHOP compared to R-CHOP in Subjects with High-Risk Diffuse Large B-Cell Lymphoma No dispute reported 06/30/2026 1202422082
Principal investigator 1 Incyte Corporation $431.70 03/06/2025 Covered Recipient Teaching Hospital
Sutter Santa Rosa Regional Hospital
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Combination of PI3Kd Inhibitor Parsaclisib and Ruxolitinib in Participants With Myelofibrosis No dispute reported 06/30/2026 1240483359
Principal investigator 1 ABBVIE INC. $18,044.93 02/06/2025 Covered Recipient Teaching Hospital
SUTTER SANTA ROSA REGIONAL HOSPITAL
M20-621 - A Phase 3 Multicenter Randomized Open-Label Trial to Evaluate Safety and Efficacy of Epcoritamab in Combination with R-CHOP compared to R-CHOP in Subjects with High-Risk Diffuse Large B-Cell Lymphoma No dispute reported 06/30/2026 1202422077
Principal investigator 1 Novartis Pharmaceuticals Corporation $78,235.51 01/01/2025 Non-covered Recipient Entity
ALTA BATES SUMMIT MEDICAL CENTER
A Phase II Multicenter, Open-label, Single-arm Dose Escalation Study of Asciminib Monotherapy in 2nd Line Chronic Phase - Chronic Myelogenous Leukemia No dispute reported 06/30/2026 1190298280